Informações:
Falhas:
ID
16852
Descrição
A Comparison of Hydrochlorothiazide and Metolazone in Combination With Furosemide in Congestive Heart Failure Patients; ODM derived from: https://clinicaltrials.gov/show/NCT00690521
Link
https://clinicaltrials.gov/show/NCT00690521
Palavras-chave
Versões (1)
- 10/08/2016 10/08/2016 -
Transferido a
10 de agosto de 2016
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Congestive Heart Failure NCT00690521
Eligibility Congestive Heart Failure NCT00690521
- StudyEvent: Eligibility
Similar models
Eligibility Congestive Heart Failure NCT00690521
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Age
Item
age >18 years
boolean
C0001779 (UMLS CUI [1])
Chronic congestive heart failure | Cardiac ejection fraction
Item
diagnosis of chronic congestive heart failure with an ejection fraction ≤45%
boolean
C0264722 (UMLS CUI [1])
C0232174 (UMLS CUI [2])
C0232174 (UMLS CUI [2])
Furosemide Therapeutic procedure Stable
Item
currently on a stable regimen of furosemide consisting of a daily dose of at least 80 mg for at least two weeks.
boolean
C0016860 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
C0205360 (UMLS CUI [1,3])
C0087111 (UMLS CUI [1,2])
C0205360 (UMLS CUI [1,3])
Angiotensin-Converting Enzyme Inhibitors Dosage Stable | Adrenergic beta-Antagonists Dosage Stable
Item
patients receiving ace-inhibitors and/or beta-blockers must be taking these medications for at least two weeks in stable doses.
boolean
C0003015 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0205360 (UMLS CUI [1,3])
C0001645 (UMLS CUI [2,1])
C0178602 (UMLS CUI [2,2])
C0205360 (UMLS CUI [2,3])
C0178602 (UMLS CUI [1,2])
C0205360 (UMLS CUI [1,3])
C0001645 (UMLS CUI [2,1])
C0178602 (UMLS CUI [2,2])
C0205360 (UMLS CUI [2,3])
Renal dysfunction | Creatinine measurement, serum | Estimation of creatinine clearance by Cockcroft-Gault formula
Item
renal dysfunction (serum creatinine >2 mg/dl or creatinine clearance of <30 ml/min as calculated by the cockroft and gault equation)
boolean
C3279454 (UMLS CUI [1])
C0201976 (UMLS CUI [2])
C2711451 (UMLS CUI [3])
C0201976 (UMLS CUI [2])
C2711451 (UMLS CUI [3])
Liver Dysfunction | Aspartate aminotransferase measurement | Alanine aminotransferase measurement
Item
hepatic dysfunction (ast and alt >3 times the upper limit of the normal)
boolean
C0086565 (UMLS CUI [1])
C0201899 (UMLS CUI [2])
C0201836 (UMLS CUI [3])
C0201899 (UMLS CUI [2])
C0201836 (UMLS CUI [3])
Hypokalemia
Item
hypokalemia (<4.0 mg/dl)
boolean
C0020621 (UMLS CUI [1])
Diuretic therapy | Furosemide | Spironolactone
Item
concomitant treatment with any diuretic other than furosemide (with the exception of spironolactone).
boolean
C0948575 (UMLS CUI [1])
C0016860 (UMLS CUI [2])
C0037982 (UMLS CUI [3])
C0016860 (UMLS CUI [2])
C0037982 (UMLS CUI [3])